{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:27:01Z","timestamp":1760646421717},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.transproceed.2015.10.052","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T08:22:23Z","timestamp":1450426943000},"page":"2968-2972","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation"],"prefix":"10.1016","volume":"47","author":[{"given":"L.","family":"Yessayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lanfear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.10.052_bib1","first-page":"281","article-title":"Immunosuppressive drugs after solid organ transplantation","volume":"71","author":"van Sandwijk","year":"2013","journal-title":"Neth J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies","volume":"7","author":"Olyaei","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.transproceed.2015.10.052_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-200565050-00004","article-title":"Combating chronic renal allograft dysfunction: optimal immunosuppressive regimens","volume":"65","author":"Merville","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2015.10.052_bib4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2015.10.052_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM198605153142005","article-title":"Renal histopathologic alterations in patients treated with cyclosporine for uveitis","volume":"314","author":"Palestine","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib8","first-page":"356","article-title":"The side-effects of ciclosporine-A and tacrolimus","volume":"49","author":"Mihatsch","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib9","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/j.transproceed.2004.01.027","article-title":"Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?","volume":"36","author":"Morozumi","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000478-199301000-00007","article-title":"The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine","volume":"17","author":"Randhawa","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib11","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.transproceed.2007.06.086","article-title":"Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation","volume":"39","author":"Cohen","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(02)07494-9","article-title":"Effect of race on outcome of orthotopic liver transplantation: a cohort study","volume":"359","author":"Nair","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2015.10.052_bib13","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.transproceed.2007.09.031","article-title":"Outcomes in adult and pediatric liver transplantation among various ethnic groups","volume":"39","author":"Neff","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib14","first-page":"3918","article-title":"Kidney graft survival rates in black cyclosporine-treated recipients. Collaborative Transplant Study","volume":"21","author":"Opelz","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM199209173271203","article-title":"Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors","volume":"327","author":"Butkus","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/lt.20069","article-title":"Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance","volume":"10","author":"Yoo","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2015.10.052_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1054\/jcaf.2003.11","article-title":"Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care","volume":"9","author":"Pamboukian","year":"2003","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.transproceed.2015.10.052_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-6143.2005.01205.x","article-title":"Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis","volume":"6","author":"Lederer","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.10.052_bib19","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African American versus white subjects in the United States: a population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1987.166","article-title":"Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity","volume":"32","author":"Barros","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2015.10.052_bib22","first-page":"568","article-title":"Cyclosporine impairs the renal response to volume depletion","volume":"20","author":"Laskow","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(90)90429-H","article-title":"Cyclosporine-induced changes in glomerular filtration rate and urea excretion","volume":"88","author":"Laskow","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","article-title":"Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function","volume":"44","author":"English","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.10.052_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/00007890-199811150-00024","article-title":"Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?","volume":"66","author":"Franz","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.10.052_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5414\/CNP58077","article-title":"Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange","volume":"58","author":"Yango","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib27","first-page":"580","article-title":"Tacrolimus-associated hemolytic uremic syndrome: a case analysis","volume":"16","author":"Lin","year":"2003","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2015.10.052_bib29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1681\/ASN.V12162","article-title":"Cellular and molecular mechanisms of cyclosporin nephrotoxicity","volume":"1","author":"Kopp","year":"1990","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0272-6386(88)80221-X","article-title":"Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension","volume":"12","author":"McClellan","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2015.10.052_bib33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archinte.1991.00400070121015","article-title":"Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?","volume":"151","author":"Whittle","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJM198910193211603","article-title":"Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes","volume":"321","author":"Cowie","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0272-6386(12)80527-0","article-title":"Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus","volume":"15","author":"Stephens","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2015.10.052_bib36","first-page":"2423","article-title":"Renal microvascular susceptibility in African American pedigrees","volume":"25","author":"Freedman","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.10.052_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ajh\/4.5.393","article-title":"Racial differences in HLA antigen frequency and hypertensive renal failure","volume":"4","author":"Freedman","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.transproceed.2015.10.052_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0272-6386(12)80806-7","article-title":"Race, socioeconomic status, and the development of end-stage renal disease","volume":"23","author":"Byrne","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2015.10.052_bib39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archinte.1995.00430110121013","article-title":"Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors","volume":"155","author":"Perneger","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2015.10.052_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ki.1994.120","article-title":"Socioeconomic status and end-stage renal disease in the United States","volume":"45","author":"Young","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2015.10.052_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group","volume":"65","author":"Neylan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.10.052_bib42","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00007890-200212150-00014","article-title":"Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression","volume":"74","author":"Mehra","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.10.052_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1522162802238650","article-title":"African American and Caucasian renal transplant recipients have equal acute rejection rates under sirolimus and tacrolimus combination therapy","volume":"5","author":"El-Sabrout","year":"2002","journal-title":"Graft"},{"key":"10.1016\/j.transproceed.2015.10.052_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2015.10.052_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.transproceed.2015.10.052_bib46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1034\/j.1600-6143.2002.21018.x","article-title":"Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients","volume":"2","author":"Maes","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.10.052_bib47","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1600-6143.2005.00844.x","article-title":"Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea","volume":"5","author":"Lemahieu","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.10.052_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clpt.2004.08.022","article-title":"Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes","volume":"76","author":"Hesselink","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2015.10.052_bib49","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000073901.94759.36","article-title":"Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients","volume":"14","author":"Anglicheau","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2015.10.052_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(03)00168-1","article-title":"Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus","volume":"74","author":"Hesselink","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2015.10.052_bib51","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515010520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515010520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T19:50:47Z","timestamp":1653853847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515010520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0041134515010520"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.10.052","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}